When Is An Invention. Nevertheless Nonobvious?

Similar documents
Obvious to Try? The Slippery Slope of Biotechnology

2010 KSR Guidelines Update, 75 FR (September 1, 2010) Updated PTO guidelines on obviousness determinations in a post KSR World

KSR INTERNATIONAL CO. v. TELEFLEX INC.: Analysis and Potential Impact for Patentees

November Obvious To Try In Pharmaceutical Formulations. g Motivation To Combine. g Obviousness-Type Double Patenting

KSR International Co. v. Teleflex Inc.: Patentability Clarity or Confusion?

Patent Prosecution. Decisions Relating to Obviousness Rejections Under 35 U.S.C. 103

The patentability criteria for inventive step I nonobviousness. The Groups are invited to answer the following questions under their national laws:

KSR International Co., v. Teleflex Inc. U.S. Supreme Court, April 2007

KSR. Managing Intellectual Property May 30, Rick Frenkel Cisco Systems Kevin Rhodes 3M Kathi Kelly Lutton F&R John Dragseth F&R

Obviousness Doctrine Post-KSR: Friend or Foe?

KSR v. TELEFLEX: HOW OBVIOUSNESS HAS CHANGED

Patent Prosecution. A. For a determination of obviousness of the subject matter under 35 U.S.C

Supreme Court of the United States KSR INTERNATIONAL CO., Petitioner, v. TELEFLEX INC. et al. No

COMPARATIVE STUDY REPORT TRILATERAL PROJECT 12.4 INVENTIVE STEP - 1 -

Comments on KSR Int'l Co. v. Teleflex, Inc.

SUPREME COURT HOLDS IN KSR CASE THAT EXPANSIVE AND FLEXIBLE OBVIOUSNESS ANALYSIS IS REQUIRED

2009 Howrey LLP 1 COMMON USPTO REJECTIONS COMMON USPTO REJECTIONS OBVIOUSNESS. Learned Hand on Obviousness. The Graham Factors

In the Wake of KSR: Sea Change or Wait-and-See?

The Patent Examination Manual. Section 10: Meaning of useful. Meaning of useful. No clear statement of utility. Specific utility

KSR Int l Co. v. Teleflex, Inc.: No Obvious Changes for the Biotechnology Market

Inventive Step and Non-obviousness: Global Perspectives

November Common Sense Approach to Obviousness. g Obvious to Try. g Obviousness-Type Double Patenting

We Innovate Healthcare 1

Royal Society of Chemistry Law Group. Recent Case Law Relevant to Chemistry

KSR v. Teleflex: Obvious Ambiguity

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit

For a patent to be valid, it needs to be useful, novel, nonobvious, and adequately

By Rebecca M. McNeill

In re Metoprolol Succinate Obviousness-Type Double Patenting Walter B. Welsh St. Onge Steward Johnston & Reens LLC Stamford, Connecticut

United States Court of Appeals for the Federal Circuit

Lev D. Gabrilovich *

Bristol-Myers Squibb Co. v. Teva Pharmaceuticals: Exploring the effect of postinvention evidence of unexpected results on 103 nonobviousness

FEDERAL CIRCUIT RESOLVES CONSTRUCTION OF PRODUCT-BY- PROCESS CLAIMS FOR INFRINGEMENT DETERMINATIONS

PATENT LAW DEVELOPMENTS

Navigating through the Obviousness-Type Double Patenting Minefield Landslide Vol. 10, No. 3 January/February 2018

Duh! Finding the Obvious in a Patent Application

Prosecuting Patent Applications: Establishing Unexpected Results

Supreme Court Invites Solicitor General s View on Safe Harbor of the Hatch-Waxman Act

The Changing Face of U.S. Patent Litigation

March 28, Re: Supplemental Comments Related to Patent Subject Matter Eligibility. Dear Director Lee:

FEDERAL CIRCUIT DECISIONS FOR WEEK ENDING AUGUST 25, 2017

Fenner Investments, Ltd. v. Cellco Partnership Impact on IPR Practice and District Court Practice

United States Court of Appeals for the Federal Circuit

Fed. Circ. Radically Changes The Law Of Obviousness

Business Method Patents on the Chopping Block?

USPTO Training Memo Lacks Sound Basis In The Law

No APOTEX, INC. and APOTEX CORP.,

Winning a Non-Obviousness Case at the Board

BNA s Patent, Trademark & Copyright Journal

Five Winning Strategies for Crafting Claims in U.S. Patent Applications

UNITED STATES COURT OF APPEALS

Claim Construction Is Ultimately A Question Of Law But May Involve Underlying Factual Questions

New Obviousness Guidelines from the USPTO and Their Impact on Prosecution

Paper No Entered: January 7, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

COMPARATIVE STUDY REPORT INVENTIVE STEP (JPO - KIPO - SIPO)

Patentable Subject Matter Utility Novelty Disclosure Req Non-obvious Patentable

UNITED STATES COURT OF APPEALS

2013 International Series Korea U.S. IP Judicial Conference. Patentability of Chemical/Pharmaceutical Inventions. Isomers/Enantiomers

The Real Issue In Fed. Circ. Dynamic Drinkware Decision

OLIVE & OLIVE, P.A. INTELLECTUAL PROPERTY LAW

Deputy Commissioner for Patent Examination Policy

Patent Law Prof. Kumar, Fall Office: Multi-Purpose Suite, Room 201R Office Phone:

HONEYWELL INTERNATIONAL INC., Appellant, v. MEXICHEM AMANCO HOLDING S.A. DE C.V., DAIKIN INDUSTRIES, LTD., Appellees. No

Written Description of the Invention: Ariad (2010) and the Overlooked Invention Priority Principle. Donald S. Chisum*

PATENT DISCLOSURE: Meeting Expectations in the USPTO

Litigating non-obviousness after KSR v Teleflex

The Patentability Search

Paper Entered: April 21, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

2010 PATENTLY O PATENT LAW JOURNAL

Lessons From Inter Partes Review Denials

Case 2:07-cv SRC-MAS Document 376 Filed 05/05/10 Page 2 of 17 U.S. Patent No. 5,211,954 (the 954 patent ), which is directed to a low-dose temaz

Inter Partes Review (IPR): Lessons from the First Year Matthew I. Kreeger

JUDGES ARE ABUSING THEIR AUTHORITY TO DETERMINE OBVIOUSNESS BY APPLYING KSR WITHOUT CHANGING THE LEGAL STANDARD OF REVIEW

Paper Entered: September 30, 2013 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

Chemical Patent Practice. Course Syllabus

In Re Klein F.3D 1343 (Fed. Cir. 2011)

Paper Entered: January 11, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

The Royal Society of Chemistry IP Law Case Seminar: 2017 in the U.S.

Patent Resources Group. Chemical Patent Practice. Course Syllabus

The Death of the Written Description Requirement? Analysis and Potential Outcomes of the Ariad Case

ENZo BIOCHEM, INC. v. GEN-PROBE, INC.

Paper Entered: January 10, 2017 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

Request for Comments on Determining Whether a Claim Element is Well- Understood, Routine, Conventional for Purposes of Subject Matter Eligibility

Should Patent Prosecution Bars Apply To Interference Counsel? 1. Charles L. Gholz 2. and. Parag Shekher 3

Working Guidelines Q217. The patentability criteria for inventive step / non-obviousness

United States Court of Appeals for the Federal Circuit

Factors That May Weigh In Favor Of, Or Against, Patentability

up eme out t of the nite tatee

Brief Summary of Precedential Patent Case Law For the Period to

Patent Claim Construction: Phillips v. AWH (Fed. Cir., July 12, 2005) (en banc) Edward D. Manzo August Patent in Suit

Case 1:09-md SLR Document 273 Filed 05/20/11 Page 1 of 7 PageID #: 5592

COMPARATIVE STUDY REPORT REQUIREMENTS FOR DISCLOSURE AND CLAIMS - 1 -

Abstract. Keywords. Kotaro Kageyama. Kageyama International Law & Patent Firm, Tokyo, Japan

-JAD SANOFI-AVENTIS DEUTSCHLAND GMBH et al v. GLENMARK PHARMACEUTICALS INC., USA et al Doc. 378 UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

United States Court of Appeals for the Federal Circuit

Adjusting the Rearview Mirror - - Blocking Impermissible Hindsight Rejections By Warren D. Woessner 1

HOW TO EVALUATE WHEN A REISSUE VIOLATES THE RECAPTURE RULE:

FEDERAL CIRCUIT DECISIONS FOR WEEK ENDING May 25, 2018

United States Court of Appeals for the Federal Circuit

Transcription:

When Is An Invention That Was Obvious To Try Nevertheless Nonobvious? This article was originally published in Volume 23, Number 3 (March 2014) of The Federal Circuit Bar Journal by the Federal Circuit Bar Association. by George M. Sirilla George M. Sirilla Intellectual Property +1.703.770.7784 george.sirilla@pillsburylaw.com George Sirilla is a partner in Pillsbury s Intellectual Property practice and is located in the firm s Northern Virginia office. He has led teams that successfully upheld, as well as invalidated, patents in numerous cases, both in the federal courts and before the U.S. International Trade Commission. I. Introduction and Summary The question in the title to this article was asked and answered in a 1988 decision of the Federal Circuit Court of Appeals that has never been overruled and is now cited and followed in the Federal Circuit. That is the case of In re O Farrell, 853 F.2d 894 (Fed. Cir. 1988). Judge Giles S. Rich wrote the opinion in that case affirming that this court and its predecessors have repeatedly emphasized that obvious to try is not the standard for invalidating patents under 103 (Id. at 903). However, he went on to explain (1) when something that is obvious to try can lead to an obvious invention and (2) when an invention that was obvious to try may nevertheless be nonobvious. (Id. at 903-904). 1 His explanations, however, were not discussed in two subsequent Federal Circuit cases that rejected an obvious to try defense. Both were decided before the Supreme Court s 2007 KSR decision, KSR International Co. v. Teleflex Inc., et al., 550 U.S. 398. Those Federal Circuit decisions stated that Obvious to try has long been held not to constitute obviousness. In re Deuel, 51 F.3d 1552, 1559 (Fed. Cir. 1995) and Teleflex Inc. v. KSR International Co., 119 Fed. Appx. 282, 290 (Fed. Cir. 2005). But in a 2007 case decided before the Supreme Court s KSR decision, the Federal Circuit cited and followed Judge Rich s holdings in the O Farrell case. That was Pfizer Inc. v. Apotex, Inc., 480 F.3d 1348, 1365 (Fed. Cir. 2007). In a later Federal Circuit case, decided after the Supreme Court s KSR decision, the court observed that the Supreme Court s KSR decision actually resurrects this court s [the Federal Circuit s] own wisdom [on obvious to try ] in Judge Rich s opinion in In re O Farrell In re Kubin, 561 F.3d 1351, 1359 (Fed. Cir. 2009). And subsequent Federal Circuit cases, consistent with KSR and the O Farrell cases, held patented inventions to be unobvious and patentable even though the ultimate unpredictable success followed initial efforts that were obvious to try. It is interesting to note that in an early (1966) Court of Customs and Patent Appeals ( CCPA ) case, Judge Rich 1 When he was in private practice, Judge Rich was intimately involved in the drafting of the applicable obviousness section of the 1952 Patent Act, 35 U.S.C. 103, and later, as the first patent lawyer to be a judge on the Court of Customs and Patent Appeals, he was highly instrumental in the proper application of the obvious standard for patentability in the courts and in the Patent Office. See 35 U.S.C. 103: From Hotchkiss to Hand to Rich, The Obvious Patent Law Hall of Famers, The John Marshall Law Review, 1999, Vol. 32, 437, 509-512, 525-531, by the present author.

suggested that obvious to try could apply to many research endeavors: Slight reflection suggests, we think, that there is an element of obviousness to try in any research endeavor, that is not undertaken with complete blindness but rather with some semblance of a chance of success, and that patentability determinations based on that as the test would not only be contrary to statute but result in a marked deterioration of the entire patent system as an incentive to invest in those efforts and attempts which go by the name of research. Tomlinson, 363 F.2d 928, 931 (CCPA 1966) (emphasis added). In his later, 1988 In re Farrell decision, Judge Rich noted that: For obviousness under 103, all that is required is a reasonable expectation of success. 853 F.2d at 904 (emphasis added). Hence, he regarded it error to apply an obvious to try defense to conclude an invention was obvious when what was relied on as obvious to try was some prior art teaching that contained no prediction or indication of a successful result, or no direction or specific guidance as to how to achieve such a result. Id. at 903-904. While Judge Rich s O Farrell case views were not discussed in a few subsequent Federal Circuit obvious to try cases decided before the KSR Supreme Court decision, the Supreme Court, in KSR, without citing O Farrell, but resurrecting Judge Rich s wisdom in that decision, held that where there are a finite number of identified, predictable solutions for solving a problem and that a person of ordinary skill has good reason to pursue the known options, if that leads to the anticipated success, that might show that it was obvious under 103. KSR, 550 U.S. at 421 (emphasis added). Conversely, therefore, if the prior art obvious to try measures that were initially followed provided or contained no identified, predictable solutions and/or provided no reasonable expectation of the success that followed, what was done that provided a successful solution might then show, pursuant to the O Farrell case, that what was obvious to try nevertheless led to an unobvious invention. Id. What I will now do is review (i) pre-ksr Federal Circuit and Court of Customs and Patent Appeals ( CCPA ) cases that considered an obvious to try defense, (ii) the Supreme Court s views on obvious to try in the KSR case, and (iii) post-ksr Federal Circuit cases involving obvious to try issues. II. CCPA and Federal Circuit Obvious to Try Cases Before the Supreme Court KSR Case A. The Tomlinson Case In the majority opinion written by Judge Rich in the 1966 Tomlinson CCPA case, supra, the Court held patentable some of the claims rejected by the Patent Office Board of Appeals, and affirmed the rejection of the other claims at issue. In a partial dissent, two of the judges agreed with the majority as to its affirmance of the claims rejected by the Patent Office, but dissented and disagreed with the majority s reversal of the Patent Office s rejection of the other claims. The key issue here was whether one skilled in the art, in seeking an ultraviolet stabilizer for polypropylene, would expect those known in the art as useful stabilizers for polyethylene to be useful stabilizers for polypropylene. Tomlinson, supra, at 932. After noting that there is usually an element of obvious to try in any research endeavor, that is not undertaken with complete blindness, but rather with some semblance of a chance of success (as noted above), the majority opinion rejected patentability determinations based on that as the test Tomlinson, supra, at 931. After considering the evidence the majority agreed with the appellants that those skilled in the art would not expect the polyethylene stabilizers to be useful stabilizers for polypropylene Id. at 932. As a result it reversed the rejection of certain claims by the Patent Office Board of Appeals. The dissent, however, disagreed and held that the only difference between appellant s claimed invention and the prior art is that they followed prior art teachings and treated polypropylene with what the art had used to stabilize polyethylene. Id. at 935. There was no further history to the case. B. The Antonie Case In 1977, the CCPA decided the Antonie case, 559 F.2d 618. In that case, as in Tomlinson, there was a dissent, but this time Judge Rich joined in the dissent. In the majority opinion, the court reversed the Patent and Trademark Office ( PTO ) Board of Appeals rejection of claims as obvious in light of the prior art. The key issue here was whether, by using routine experimentation, the prior art teachings would enable one skilled in the art to develop the claimed invention. In reversing the PTO, the majority opinion noted that:

When Is An Invention That Was Obvious To Try Nevertheless Nonobvious? The PTO and the minority appear to argue that it would always be obvious for one of ordinary skill in the art to try varying every parameter of a system in order to optimize the effectiveness of the system even if there is no evidence in the record that the prior art recognized that particular parameter affected the result. As we have said many times, obvious to try is not the standard of 35 U.S.C. 103. [citing Tomlinson]. Disregard for the unobviousness of the results of obvious to try experiments disregards the invention as a whole concept of 103, [citing cases], and overemphasis on the routine nature of the data gathering required to arrive at appellant s discovery, after its existence became expected, overlooks the last sentence of 103. [citing cases]. Antonie, 559 F.2d at 620 (emphasis added). The dissent, on the other hand, concluded that in view of the prior art, only routine experimentation was required to arrive at the claimed invention, and would therefore affirm the PTO decision. Given the basic apparatus of El-Naggar and the concept of varying the number of disks in a tank in order to optimize impurity removal, I believe that it would have been well within the capabilities of the chemical engineer of ordinary skill to determine empirically, by routine experimentation, the optimum design ratio which appellant has determined and recited in his claims. That is, El-Naggar set the way, and appellant s work was what any routineer would have accomplished in following the patent teachings. However, obviousness under 35 U.S.C. 103 does not require absolute predictability, [citing cases], and it is sufficient here that El-Naggar clearly led the way for the routineer to arrive at the claimed apparatus.id. at 621 (emphasis added). C. The O Farrell Case In the 1988 Federal Circuit O Farrell case, supra, the court affirmed the PTO s decision rejecting the claims on obviousness. As noted above, Judge Rich wrote the opinion in this case, and there was no dissent. In this case, there was an early publication by two of the three coinventors that was relied on to reject the claims, and the court affirmed the rejection: Appellants published their pioneering studies of the expression of frog ribosomal RNA genes in bacteria more than a year before they applied for a patent. After providing virtually all of their method to the public without applying for a patent within a year, they foreclosed themselves from obtaining a patent on a method that would have been obvious from their publication to those of ordinary skill in the art, with or without the disclosures of other prior art. O Farrell, supra, at 904. In considering the obviousness issue, the court noted that the applicants argued that the rejection [by the PTO] amounts to the application of a standard of obvious to try to the field of molecular biology, a standard which this court and its predecessors have repeatedly rejected as improper grounds for a 103 rejection. [citing cases]. Id. at 902. However, the court went on to note: It is true that this court and its predecessors have repeatedly emphasized that obvious to try is not the standard under 103. However, the meaning of this maxim is sometimes lost. Any invention that would in fact have been obvious under 103 would also have been, in a sense, obvious to try. The question is: when is an invention that was obvious to try nevertheless nonobvious? Id. at 903 (emphasis added). The court then added that the admonition that obvious to try is not the standard under 103 has been directed mainly at two kinds of error. Id. The two kinds of error are (1) where the prior art gave either no indication of which parameters were critical or no direction as to which of many possible choices is likely to be successful [citing cases], and (2) in exploring a new technology or general approach that seemed to be a promising field of experimentation, where the prior art gave only general guidance as to the particular form of the claimed invention or how to achieve it. Id. The court went on to note: Obviousness does not require absolute predictability of success. Indeed, for many inventions that seem quite obvious, there is no absolute predictability of success until the invention is reduced to practice. There is always at least a possibility of unexpected results, that would then provide an objective basis for showing that the invention, although apparently obvious, was in law nonobvious. [citing cases]. Id. at 903-904.

The court then concluded that For obviousness under 103, all that is required is a reasonable expectation of success. [citing cases]. Id. at 904 (emphasis added). Hence, if there is no reasonable expectation of success in what was initially obvious to try, the later successful result might then be regarded as nevertheless nonobvious if it could be shown that reaching the successful result would not have been obvious to a person of ordinary skill in the art. D. The Deuel Case In a 1995 case, In re Deuel, 51 F.3d 1552 (Fed. Cir. 1995), the invention related to isolated and purified DNA and cdna molecules encoding heparinbinding growth factors Id. at 1554. The court cited and partially followed O Farrell, reversing the PTO decision and held the claims allowable. The court concluded that prior art suggesting the claimed compound was lacking and added that: Obvious to try has long been held not to constitute obviousness. [citing O Farrell]. A general incentive does not make obvious a particular result, nor does the existence of techniques by which those efforts can be carried out. Thus, Maniatis s teachings, even in combination with Bohlen, fail to suggest the claimed invention. Id. at 1559 (emphasis added). The court, however, failed to consider the discussion in the O Farrell case as to when obvious to try could be a good defense and when it could not be. E. The Teleflex Case In its 2005 decision in Teleflex, Inc. v. KSR International Co., 119 Fed. Appx. 282 (Fed. Cir. 2005), the Federal Circuit reversed the district court s summary judgment of invalidity. The invention related to electronic throttle controlled automobile engines involving an adjustable pedal position and an electronic pedal position sensor. In reversing the District Court, the Federal Circuit held that the district court erred as a matter of law by applying an incomplete teaching-suggestion-motivation test to its obviousness determination. Id. at 290. On the issue of obvious to try, all the court said, quoting the In re Deuel case, 51 F.3d at 1559, was: Obvious to try has long been held not to constitute obviousness. Id. at 289. No reference was made to the O Farrell case. F. The Pfizer Case Pfizer, Inc. v. Apotex, Inc., 480 F.3d 1348 (Fed. Cir. 2007), was decided March 22, 2007, a little more than a month before the Supreme Court s April 30, 2007 KSR decision. In the Pfizer case, the court held the claims invalid, reversing the district court s judgment. The claims were directed to a pharmaceutical product covered by a Pfizer patent. On the obvious to try issue, and citing O Farrell, the court held that for obviousness to apply to a particular known method that was obvious to try, the expectation of success need only be reasonable, not absolute In re O Farrell, 853 F.2d 894, 903 (Fed. Cir. 1988). Pfizer, supra, at 1364. Again citing O Farrell, the court added: But, once again, only a reasonable expectation of success, not a guarantee is needed. O Farrell, 853 F.2d at 903 Pfizer, supra, at 1364; and this is not the case where the prior art teaches merely to pursue a general approach that seems to be a promising field of experimentation or gave only generic guidance as to the particular form of the claimed invention or how to achieve it, O Farrell, 853 F.2d at 903 Pfizer, supra, at 1366. In conclusion, in rejecting the claims, the court held that a skilled artisan would have had a reasonable expectation of success [in pursuing what was obvious to try]. Id. at 1369. III. The Supreme Court KSR Decision The court noted that the invention here related to an adjustable pedal system for cars with cable-actuated throttles. KSR, supra, at 399. To better understand the Supreme Court s reversal, the following additional comments on the Federal Circuit s decision are provided. The Federal Circuit had vacated the District Court s grant of summary judgment of invalidity, rejecting as insufficient to support a finding of obviousness, testimony that an electronic control could have been mounted on the support bracket of a pedal assembly See e.g. In re Deuel, 51 F.3d 1552, 1559 (Fed. Cir. 1995). ( Obvious to try has long been held not to constitute obviousness. ) Teleflex, supra, 119 Fed. Appx. at 289. Then, as noted above, the Federal Circuit concluded its decision by holding that: the district court erred as a matter of law by applying an incomplete teaching-suggestion-motivation test to its obviousness determination. Teleflex, supra, 119 Fed. Appx. at 290.

When Is An Invention That Was Obvious To Try Nevertheless Nonobvious? In reversing the Federal Circuit s decision that had vacated and remanded the District Court s decision granting summary judgment of invalidity, the Supreme Court concluded that the flaws in the analysis of the court of appeals relate for the most part to the court s narrow conception of the obviousness inquiry reflected in its application of the TSM [teaching-suggestion-motivation] test. KSR, supra, at 419. Then, considering the obvious to try issue, the Supreme Court held: The same constricted analysis led the Court of Appeals to conclude, in error, that a patent claim cannot be proved obvious merely by showing that the combination of elements was obvious to try. When there is a design need or market pressure to solve a problem and there are a finite number of identified, predictable solutions a person of ordinary skill has good reason to pursue the known options within his or her technical grasp. If this leads to the anticipated success, it is likely the product not of innovation but of ordinary skill and common sense. In that instance the fact that a combination was obvious to try might show that it was obvious under 103. KSR, supra, at 421 (emphasis added). To summarize that holding, if what was pursued was something obvious to try that included predictable solutions and it led to the anticipated success, then the fact that it was obvious to try might show that it was obvious under 103. Id. In making that holding, the Supreme Court did not cite Judge Rich s similar holding in the O Farrell case. IV. Federal Circuit Cases After the Supreme Court KSR Case A. The Kubin Case In this case, the Federal Circuit affirmed a PTO decision that rejected a claimed gene sequence as unpatentable because it was obvious in light of the prior art. On the obvious to try issue, the court noted that: the Supreme Court recently cast doubt on the viability of Deuel to the extent the Federal Circuit rejected an obvious to try test. [citing authority]. Under KSR, it s now apparent obvious to try may be an appropriate test in more situations than we previously contemplated. In re Kubin, 531 F.3d 1351, 1358 (Fed. Cir. 2009) (emphasis added). The court then went on to refer to the Supreme Court s consideration of the obvious to try defense quoted and discussed above, noting that: The Supreme Court s admonition against a formalistic approach to obviousness in this context actually resurrects this court s own wisdom in In re O Farrell, which predates the Deuel decision by some seven years Kubin, supra, at 1359. The court then referred to the two classes of situations outlined in the O Farrell case where obvious to try is erroneously equated with obviousness under 103. Id. The first situation is where the prior art gave either no indication of which parameters were critical or no direction as to which of many possible choices is likely to be successful. Id. The second is where a new technology or general approach is explored but where the prior art gave only general guidance as to the particular form of the claimed invention or how to achieve it. Id. The court then noted that: This court in O Farrell found the patentee s claims obvious because the Board s rejection of the patentee s claims had not presented either of the two common obvious to try pitfalls. Specifically, this court observed that an obviousness finding was appropriate where the prior art contained detailed enabling methodology for practicing the claimed invention, a suggestion to modify the prior art to practice the claimed invention, and evidence suggesting that it would be successful. 853 F.2d at 902 (emphasis added). Responding to concerns about uncertainty in the prior art influencing the purported success of the claimed combination, this court stated: [o]bviousness does not require absolute predictability of success all that is required is a reasonable expectation of success. Id. at 903-904 (emphasis added). The Supreme Court in KSR reinvigorated this perceptive analysis. Id. at 1360. The court concluded: As the Board found, the prior art here provides a reasonable expectation of success for obtaining a polynucleotide within the scope of claim 73, Board Decision at 6, which, [f ] or obviousness under 103 [is] all that is required. O Farrell, 853 F.2d at 903. Thus, this court affirms the Board s conclusion as to obviousness. Id. at 1361.

When Is An Invention That Was Obvious To Try Nevertheless Nonobvious? B. Other Post KSR Federal Circuit Cases Other Federal Circuit cases have cited and followed the Supreme Court s KSR decision on obvious to try, some of which also cited and followed the O Farrell case s holdings on obvious to try. Cases citing and following KSR on obvious to try issues include: Abbott Laboratories v. Sandoz, Inc., 544 F.3d 1341, 1351-52 (Fed. Cir. 2009), also citing Tomlinson but not O Farrell; Sanofi-Synthelabs v. Apotex, Inc., 550 F.3d 1075, 1090 (Fed. Cir. 2008, 2009), holding the claims patentable because the result of what was obvious to try was unpredictable, but not citing O Farrell; Proctor & Gamble Co. v. Teva Pharmaceuticals USA, Inc., 566 F.3d 989, 996 (Fed. Cir. 2009), holding the claims patentable and citing O Farrell for its discussion of when an obvious to try approach may nevertheless lead to an unobvious invention (Id. at 996-997); Bayer Schering Pharma AG v. Barr Laboratories, Inc., 575 F.3d 1341, 1347, 1350 (Fed. Cir. 2009), also citing O Farrell at 1347, 1349, 1350 but holding what was obvious to try led to an obvious invention; Perfect Web Technologies, Inc. v. InfoUSA, Inc., 587 F.3d 1324, 1331 (Fed. Cir. 2009), also citing O Farrell at 1331 in holding what was obvious to try led to an obvious invention; Rolls Royce, PLC v. United Technologies Corp., 603 F.3d 1325, 1339 (Fed. Cir. 2010), holding for its non-obvious decision that the invention would not have presented itself as an option at all, let alone an option that would have been obvious to try (Id. at 1339). V. Conclusion The purpose of this article is to consider how the courts have treated inventions where the initial efforts that were made were obvious to try. As Judge Rich noted in the Tomlinson case, however, there can be an element of obvious to try in any serious research endeavor. So how should the courts deal with attacks on patented inventions when the initial efforts were obvious to try? As Judge Rich concluded in the O Farrell case, the court should not simply say obvious to try is no defense and dismiss it since it can be applied as a defense in those cases as described. Furthermore, in concluding this article and in answer to Judge Rich s O Farrell case question in the title to this article, and as held by the Supreme Court in the KSR case and in subsequent Federal Circuit cases, it will be seen: that an invention where the initial efforts were obvious to try might nevertheless be a valid and unobvious invention if what was obvious to try did not provide or include a reasonable expectation of achieving the successful invention that ultimately resulted. Clearly, from the cases that followed O Farrell, Judge Rich had it right in his 1966 Tomlinson and 1988 O Farrell decisions. 1540 Broadway New York, NY 10036 +1.877.323.4171 ATTORNEY ADVERTISING. Results depend on a number of factors unique to each matter. Prior results do not guarantee a similar outcome. 2014. All rights reserved.